ACUTE EFFECTS OF CYTOTOXIC COMPOUNDS ON INCORPORATION OF PRECURSORS INTO DNA, RNA, AND PROTEIN OF HELA MONOLAYERS.
D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D004247:DNA; D003609:Dactinomycin; D005467:Floxuridine; D006367:HeLa Cells; D006801:Humans; D007930:Leucine; D015122:Mercaptopurine; D008660:Metabolism; D008727:Methotrexate; D009705:Nucleosides; D010600:Pharmacology; D011506:Proteins / Q000378:metabolism*; D011691:Puromycin; D012313:RNA; D012106:Research; D013308:Streptonigrin; D013936:Thymidine; D046509:Tissue Culture Techniques; D014265:Triethylenemelamine; D014520:Urethane; D014529:Uridine; D014747:Vinblastine
D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D009705:Nucleosides; D011506:Proteins; D005467:Floxuridine; D003609:Dactinomycin; D013308:Streptonigrin; D014520:Urethane; D011691:Puromycin; D014747:Vinblastine; D012313:RNA; D004247:DNA; D015122:Mercaptopurine; D014265:Triethylenemelamine; D007930:Leucine; D013936:Thymidine; D014529:Uridine; D008727:Methotrexate
ACTINOMYCIN; ANTIBIOTICS; ANTIMETABOLITES; DNA; EXPERIMENTAL LAB STUDY; FLUORODEOXYURIDINE; HELA CELLS; LEUCINE; MERCAPTOPURINE; METABOLISM; METHOTREXATE; NUCLEOSIDES; PHARMACOLOGY; PROTEIN METABOLISM; PUROMYCIN; RNA; STREPTONIGRIN; THYMIDINE; TISSUE CULTURE; TRIETHYLENE MELAMINE; URETHANE; URIDINE; VINBLASTINE